Skip to main content
Top
Published in: BMC Public Health 1/2014

Open Access 01-12-2014 | Research article

First-year results of the Global Influenza Hospital Surveillance Network: 2012–2013 Northern hemisphere influenza season

Authors: Joan Puig-Barberà, Anita Tormos, Anna Sominina, Elena Burtseva, Odile Launay, Meral A Ciblak, Angels Natividad-Sancho, Amparo Buigues-Vila, Sergio Martínez-Úbeda, Cedric Mahé

Published in: BMC Public Health | Issue 1/2014

Login to get access

Abstract

Background

The Global Influenza Hospital Surveillance Network (GIHSN) was developed to improve understanding of severe influenza infection, as represented by hospitalized cases. The GIHSN is composed of coordinating sites, mainly affiliated with health authorities, each of which supervises and compiles data from one to seven hospitals. This report describes the distribution of influenza viruses A(H1N1), A(H3N2), B/Victoria, and B/Yamagata resulting in hospitalization during 2012–2013, the network’s first year.

Methods

In 2012–2013, the GIHSN included 21 hospitals (five in Spain, five in France, four in the Russian Federation, and seven in Turkey). All hospitals used a reference protocol and core questionnaire to collect data, and data were consolidated at five coordinating sites. Influenza infection was confirmed by reverse-transcription polymerase chain reaction. Hospitalized patients admitted within 7 days of onset of influenza-like illness were included in the analysis.

Results

Of 5034 patients included with polymerase chain reaction results, 1545 (30.7%) were positive for influenza. Influenza A(H1N1), A(H3N2), and both B lineages co-circulated, although distributions varied greatly between coordinating sites and over time. All age groups were affected. A(H1N1) was the most common influenza strain isolated among hospitalized adults 18–64 years of age at four of five coordinating sites, whereas A(H3N2) and B viruses were isolated more often than A(H1N1) in adults ≥65 years of age at all five coordinating sites. A total of 16 deaths and 20 intensive care unit admissions were recorded among patients with influenza.

Conclusions

Influenza strains resulting in hospitalization varied greatly between coordinating sites and over time. These first-year results of the GIHSN are relevant, useful, and timely. Due to its broad regional representativeness and sustainable framework, this growing network should contribute substantially to understanding the epidemiology of influenza, particularly for more severe disease.
Appendix
Available only for authorised users
Literature
2.
go back to reference Paget J, Marquet R, Meijer A, van der Velden K: Influenza activity in Europe during eight seasons (1999–2007): an evaluation of the indicators used to measure activity and an assessment of the timing, length and course of peak activity (spread) across Europe. BMC Infect Dis. 2007, 7: 141-10.1186/1471-2334-7-141.CrossRefPubMedPubMedCentral Paget J, Marquet R, Meijer A, van der Velden K: Influenza activity in Europe during eight seasons (1999–2007): an evaluation of the indicators used to measure activity and an assessment of the timing, length and course of peak activity (spread) across Europe. BMC Infect Dis. 2007, 7: 141-10.1186/1471-2334-7-141.CrossRefPubMedPubMedCentral
3.
go back to reference Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ, Fukuda K: Influenza-associated hospitalizations in the United States. JAMA. 2004, 292 (11): 1333-1340. 10.1001/jama.292.11.1333.CrossRefPubMed Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ, Fukuda K: Influenza-associated hospitalizations in the United States. JAMA. 2004, 292 (11): 1333-1340. 10.1001/jama.292.11.1333.CrossRefPubMed
4.
go back to reference Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, Fukuda K: Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003, 289 (2): 179-186. 10.1001/jama.289.2.179.CrossRefPubMed Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, Fukuda K: Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003, 289 (2): 179-186. 10.1001/jama.289.2.179.CrossRefPubMed
5.
go back to reference Brammer L, Budd A, Cox N: Seasonal and pandemic influenza surveillance considerations for constructing multicomponent systems. Influenza Other Respir Viruses. 2009, 3 (2): 51-58. 10.1111/j.1750-2659.2009.00077.x.CrossRefPubMedPubMedCentral Brammer L, Budd A, Cox N: Seasonal and pandemic influenza surveillance considerations for constructing multicomponent systems. Influenza Other Respir Viruses. 2009, 3 (2): 51-58. 10.1111/j.1750-2659.2009.00077.x.CrossRefPubMedPubMedCentral
6.
go back to reference Ortiz JR, Sotomayor V, Uez OC, Oliva O, Bettels D, McCarron M, Bresee JS, Mounts AW: Strategy to enhance influenza surveillance worldwide. Emerg Infect Dis. 2009, 15 (8): 1271-1278. 10.3201/eid1508.081422.CrossRefPubMedPubMedCentral Ortiz JR, Sotomayor V, Uez OC, Oliva O, Bettels D, McCarron M, Bresee JS, Mounts AW: Strategy to enhance influenza surveillance worldwide. Emerg Infect Dis. 2009, 15 (8): 1271-1278. 10.3201/eid1508.081422.CrossRefPubMedPubMedCentral
7.
go back to reference World Health Organization: WHO Interim Global Epidemiological Surveillance Standards for Influenza. 2012 World Health Organization: WHO Interim Global Epidemiological Surveillance Standards for Influenza. 2012
8.
go back to reference Kelly HA, Sullivan SG, Grant KA, Fielding JE: Moderate influenza vaccine effectiveness with variable effectiveness by match between circulating and vaccine strains in Australian adults aged 20–64 years, 2007–2011. Influenza Other Respir Viruses. 2013, 7 (5): 729-737. 10.1111/irv.12018.CrossRefPubMed Kelly HA, Sullivan SG, Grant KA, Fielding JE: Moderate influenza vaccine effectiveness with variable effectiveness by match between circulating and vaccine strains in Australian adults aged 20–64 years, 2007–2011. Influenza Other Respir Viruses. 2013, 7 (5): 729-737. 10.1111/irv.12018.CrossRefPubMed
9.
go back to reference Ohmit SE, Petrie JG, Malosh RE, Cowling BJ, Thompson MG, Shay DK, Monto AS: Influenza vaccine effectiveness in the community and the household. Clin Infect Dis. 2013, 56 (10): 1363-1369. 10.1093/cid/cit060.CrossRefPubMedPubMedCentral Ohmit SE, Petrie JG, Malosh RE, Cowling BJ, Thompson MG, Shay DK, Monto AS: Influenza vaccine effectiveness in the community and the household. Clin Infect Dis. 2013, 56 (10): 1363-1369. 10.1093/cid/cit060.CrossRefPubMedPubMedCentral
10.
go back to reference Public health Agency of Canadian Institutes of Health Research Influenza Research Network (PCIRN): PHAC/CIHR Influenza Research Network 2013 Annual Report. 2013 Public health Agency of Canadian Institutes of Health Research Influenza Research Network (PCIRN): PHAC/CIHR Influenza Research Network 2013 Annual Report. 2013
11.
go back to reference Skowronski DM, De Serres G, Dickinson J, Petric M, Mak A, Fonseca K, Kwindt TL, Chan T, Bastien N, Charest H, Li Y: Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006–2007. J Infect Dis. 2009, 199 (2): 168-179. 10.1086/595862.CrossRefPubMed Skowronski DM, De Serres G, Dickinson J, Petric M, Mak A, Fonseca K, Kwindt TL, Chan T, Bastien N, Charest H, Li Y: Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006–2007. J Infect Dis. 2009, 199 (2): 168-179. 10.1086/595862.CrossRefPubMed
12.
go back to reference Valenciano M, Ciancio B, team IMs: I-MOVE: a European network to measure the effectiveness of influenza vaccines. Euro Surveill. 2012, 17: 39- Valenciano M, Ciancio B, team IMs: I-MOVE: a European network to measure the effectiveness of influenza vaccines. Euro Surveill. 2012, 17: 39-
13.
go back to reference Michiels B, Govaerts F, Remmen R, Vermeire E, Coenen S: A systematic review of the evidence on the effectiveness and risks of inactivated influenza vaccines in different target groups. Vaccine. 2011, 29 (49): 9159-9170. 10.1016/j.vaccine.2011.08.008.CrossRefPubMed Michiels B, Govaerts F, Remmen R, Vermeire E, Coenen S: A systematic review of the evidence on the effectiveness and risks of inactivated influenza vaccines in different target groups. Vaccine. 2011, 29 (49): 9159-9170. 10.1016/j.vaccine.2011.08.008.CrossRefPubMed
14.
go back to reference Baker M, Kelly H, Wilson N: Pandemic H1N1 influenza lessons from the southern hemisphere. Euro Surveill. 2009, 14: 42- Baker M, Kelly H, Wilson N: Pandemic H1N1 influenza lessons from the southern hemisphere. Euro Surveill. 2009, 14: 42-
15.
go back to reference Beaute J, Broberg E, Plata F, Bonmarin I, OD J, Delgado C, Boddington N, Snacken R: Overrepresentation of influenza A(H1N1)pdm09 virus among severe influenza cases in the 2011/12 season in four European countries. Euro Surveill. 2012, 17: 9- Beaute J, Broberg E, Plata F, Bonmarin I, OD J, Delgado C, Boddington N, Snacken R: Overrepresentation of influenza A(H1N1)pdm09 virus among severe influenza cases in the 2011/12 season in four European countries. Euro Surveill. 2012, 17: 9-
16.
go back to reference Poehling KA, Edwards KM, Griffin MR, Szilagyi PG, Staat MA, Iwane MK, Snively BM, Suerken CK, Hall CB, Weinberg GA, Chaves SS, Zhu Y, McNeal MM, Bridges CB: The burden of influenza in young children, 2004–2009. Pediatrics. 2013, 131 (2): 207-216. 10.1542/peds.2012-1255.CrossRefPubMedPubMedCentral Poehling KA, Edwards KM, Griffin MR, Szilagyi PG, Staat MA, Iwane MK, Snively BM, Suerken CK, Hall CB, Weinberg GA, Chaves SS, Zhu Y, McNeal MM, Bridges CB: The burden of influenza in young children, 2004–2009. Pediatrics. 2013, 131 (2): 207-216. 10.1542/peds.2012-1255.CrossRefPubMedPubMedCentral
17.
go back to reference Williamson DA, Huang QS, Roberts SA, Grant CC, McArthur C, Baker MG: Surveillance for influenza using hospital discharge data may underestimate the burden of influenza-related hospitalization. Infect Control Hosp Epidemiol. 2012, 33 (10): 1064-1066. 10.1086/667742.CrossRefPubMed Williamson DA, Huang QS, Roberts SA, Grant CC, McArthur C, Baker MG: Surveillance for influenza using hospital discharge data may underestimate the burden of influenza-related hospitalization. Infect Control Hosp Epidemiol. 2012, 33 (10): 1064-1066. 10.1086/667742.CrossRefPubMed
19.
go back to reference Fiore AE, Uyeki TM, Broder K, Finelli L, Euler GL, Singleton JA, Iskander JK, Wortley PM, Shay DK, Bresee JS, Cox NJ, Centres for Disease Control and Prevention (CDC): Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep. 2010, 59 (RR-8): 1-62.PubMed Fiore AE, Uyeki TM, Broder K, Finelli L, Euler GL, Singleton JA, Iskander JK, Wortley PM, Shay DK, Bresee JS, Cox NJ, Centres for Disease Control and Prevention (CDC): Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep. 2010, 59 (RR-8): 1-62.PubMed
20.
go back to reference Foppa IM, Haber M, Ferdinands JM, Shay DK: The case test-negative design for studies of the effectiveness of influenza vaccine. Vaccine. 2013, 31 (30): 3104-3109. 10.1016/j.vaccine.2013.04.026.CrossRefPubMed Foppa IM, Haber M, Ferdinands JM, Shay DK: The case test-negative design for studies of the effectiveness of influenza vaccine. Vaccine. 2013, 31 (30): 3104-3109. 10.1016/j.vaccine.2013.04.026.CrossRefPubMed
23.
go back to reference Paul Glezen W, Schmier JK, Kuehn CM, Ryan KJ, Oxford J: The burden of influenza B: a structured literature review. Am J Public Health. 2013, 103 (3): e43-e51. 10.2105/AJPH.2012.301137.CrossRefPubMedPubMedCentral Paul Glezen W, Schmier JK, Kuehn CM, Ryan KJ, Oxford J: The burden of influenza B: a structured literature review. Am J Public Health. 2013, 103 (3): e43-e51. 10.2105/AJPH.2012.301137.CrossRefPubMedPubMedCentral
24.
go back to reference Vaccine European New Integrated Collaboration Effort: Seasonal influenza vaccination survey in EU/EEA, influenza season 2009–10. 2011 Vaccine European New Integrated Collaboration Effort: Seasonal influenza vaccination survey in EU/EEA, influenza season 2009–10. 2011
25.
go back to reference Tuppin P, Choukroun S, Samson S, Weill A, Ricordeau P, Allemand H: [Vaccination against seasonal influenza in France in 2010 and 2011: decrease of coverage rates and associated factors]. Presse Med. 2012, 41 (11): e568-e576. 10.1016/j.lpm.2012.05.017.CrossRefPubMed Tuppin P, Choukroun S, Samson S, Weill A, Ricordeau P, Allemand H: [Vaccination against seasonal influenza in France in 2010 and 2011: decrease of coverage rates and associated factors]. Presse Med. 2012, 41 (11): e568-e576. 10.1016/j.lpm.2012.05.017.CrossRefPubMed
26.
go back to reference Osterholm MT, Kelley NS, Sommer A, Belongia EA: Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2012, 12 (1): 36-44. 10.1016/S1473-3099(11)70295-X.CrossRefPubMed Osterholm MT, Kelley NS, Sommer A, Belongia EA: Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2012, 12 (1): 36-44. 10.1016/S1473-3099(11)70295-X.CrossRefPubMed
Metadata
Title
First-year results of the Global Influenza Hospital Surveillance Network: 2012–2013 Northern hemisphere influenza season
Authors
Joan Puig-Barberà
Anita Tormos
Anna Sominina
Elena Burtseva
Odile Launay
Meral A Ciblak
Angels Natividad-Sancho
Amparo Buigues-Vila
Sergio Martínez-Úbeda
Cedric Mahé
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2014
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-14-564

Other articles of this Issue 1/2014

BMC Public Health 1/2014 Go to the issue